hard · CFA Level I equity
Amberfen Pharma (IFRS) has a book value per share (B₀) of 25.00. Current year net income is forecast at 4.00 per share, with dividends of 1.00. However, Amberfen expects an unrealized loss of 0.50 per share on FVOCI securities, which will be recorded in Accumulated Other Comprehensive Income (AOCI). The cost of equity (r) is 10% and the long-term growth rate (g) of residual income is 3%. An analyst notes that the $0.50 OCI loss violates the clean surplus relationship. If the analyst fails to adjust for this violation when forecasting future book values, the intrinsic value estimate will likely be:
- Unaffected
- Understated
- Overstated
Sign up free to see the explanation and track your rank →
More CFA Level I equity practice
- Helion Rail just paid a $1.80 dividend. If the long-term growth rate is 5% and the require
- Helion Rail just paid a dividend of $3.00. Growth is 2% and the required return is 8%. The
- Helion Rail recently paid a dividend of $4.20. Growth is 3% and the required return is 9%.
- Helion Rail recently distributed a dividend of $0.50. Growth is 6% and the required return
- A price-weighted index contains three stocks priced at 20, 50, and 90. If the 90 stock und
- Meridian Pack paid a $2.00 dividend yesterday. The dividend is expected to grow at 4% per
- An analyst at Helion Rail is asked to identify the 'sustaina… — Which two inputs are requi
- Solas Energy's common stock is currently trading at $45.00. The firm is expected to pay a